Benralizumab T10497
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Benralizumab (MEDI-563) is an IL-5R_-directed cytolytic monoclonal antibody that induces rapid, direct and nearly complete depletion of eosinophils via enhanced antibody-dependent cell-mediated cytotoxicity. It can be used for severe eosinophilic asthma.
CAS nr:
1044511-01-4
Purity:
98%
Molecular Weight:
SMILES:
Formula:
Pathway:
Immunology/Inflammation
Target:
IL Receptor
